Burgess Paul D.

CIK 00017446272 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001744627

Recent Transactions

18 trades

Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2024-08-01−81,065→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−45,727→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-08-01−95,931→ 0 total
Award
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2024-01-19+81,065→ 81,065 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2023-12-19−23,847→ 0 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-12-19+23,847→ 45,727 total
Purchase
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-08-04$22.93/sh+21,880→ 21,880 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-07-03+95,931→ 95,931 total
Award
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2023-07-03+23,847→ 23,847 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−69,953→ 0 total
Sale
Translate Bio, Inc.
Common Stock
2021-09-14$38.00/sh−71,833→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−150,000→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−150,000→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−90,000→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−219,652→ 0 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2021-03-09+90,000→ 90,000 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2020-03-03+150,000→ 150,000 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2019-03-08+150,000→ 150,000 total

Companies

Recent Filings

Address

C/O TRANSLATE BIO, INC. 29 HARTWELL AVENUE

LEXINGTON, MA, 02421

View on SEC.gov